The Role of MicroRNAs in the Progression, Prognostication, and Treatment of Breast Cancer_Crimson Publishers

The Role of MicroRNAs in the Progression, Prognostication, and Treatment of Breast Cancer by Yi Lu in Journal of Cancer Research

 

Crimson Publishers_ Novel Approaches in Cancer Study 

MicroRNAs (miRNAs) are conserved, small, non-coding RNA molecules, which recently have attracted enormous attention in numerous physiological and pathological conditions. Several studies have shed light on their biogenesis, regulatory mechanisms, and role as effective therapies in diseased conditions. Of interest, miRNA deregulation in numerous cancer types has been researched as potential diagnostic and prognostic tool. Breast cancer (BCa) is the most predominant tumor in women and the main cause of death. Despite advances in diagnosis and new treatments, the death toll from this disease is still higher than many other types of cancer in men and women. A major global health issue plaguing the health and clinical research industry is resistance to BCa treatments. A lot of attention is increasingly directed towards miRNAs as a potential predictor’s response to treatments and as an alternative therapy to BCa treatment. Increasing evidence reveals a fundamental role miRNA plays in cancer development, progression, and treatment. Repeated findings have reinforced evidence of miRNA modulations in breast cancer cells by their effects in cell migration and invasion. Recently, miRNAs have been described as a diagnostic and prognostic tool, which offers promises as biomarkers for advancement of non-invasive and precise methods for screening tumor growth and progression. This review summarizes an overview of miRNA in breast cancer growth and progression, recent applications as biomarkers in a clinical setting in this type of cancers.

https://crimsonpublishers.com/nacs/fulltext/NACS.000582.php

For more Open Access Journals in Crimson Publishers please click on: https://crimson-publishers.blogspot.com/2019/10/crimson-publishers-impact-factor.html

For more Articles in Novel Approaches in Cancer Study please click on: https://crimsonpublishers.com/nacs/index.php

Comments

Post a Comment

Popular posts from this blog

Recent Advances in the Therapeutic Approaches of Glioblastoma Multiforme_Crimson Publishers

Image
  Recent Advances in the Therapeutic Approaches of Glioblastoma Multiforme by Siddharth Shah in  in Novel Approaches in Cancer Study Abstract Glioblastoma Multiforme (GBM, WHO grade IV) is one of the most aggressive, invasive, and lethal intracranial neoplasms, with a low post-diagnosis survival rate. Standard-of-care treatment regimens involving maximal surgical resection, radiotherapy, and genetic anti-tumor compounds like Temozolomide have only been marginally effective in improving overall survival and quality of life. Cell fusion, autophagy, and other complex biological processes affecting GBM pathophysiology are being studied to improve GBM treatment. This paper therefore focuses on oncolytic virus therapy combined with surgical resection, photodynamic therapy, and novel gene therapy, demonstrating how GBM treatment for patients could result in immediate and authentic tumor cytotoxicity and removal, rather than treatment of recurrent GBM. Standard therapy for GBM,...
Read more

Release of Inorganic Phosphate into the Tumor Environment: Possible Roles of Ecto- Nucleotidases and Ecto-Phosphatases

Abstract Inorganic phosphate (Pi) is essential for several biochemical reaction. Serum Pi is maintained at relatively narrow range concentrations, between 0.7 and 1.55mM. Tumor microenvironment presents a high Pi concentration (1.8±0.2mM Pi) and this could be associated wi the rapid growth in the “Growth Rate Hypothesis”. Several studies have identified high expression of Pi transporters in various tumor tissues. Similarly, ecto-enzymes (like ecto-nucleotidases or ecto- phosphates) act by dephosphorylating phosphosubstrates in the extracellular environment, and its high expression has been observed in various types of cancer. Little is known about the function of these ecto-enzymes on Pi releasing and accumulation in the tumor environment. Therefore, the purpose of this study is to correlate a possible contribution of the Pi release in the tumor microenvironment by ecto-nucleotidases and ecto-phosphatases, concomitant to the regulation of Pi extracellular pool by specific Pi...
Read more

Release of Inorganic Phosphate into the Tumor Environment: Possible Roles of Ecto- Nucleotidases and Ecto-Phosphatases_Crimson Publishers

Image
Release of Inorganic Phosphate into the Tumor Environment: Possible Roles of Ecto- Nucleotidases and Ecto-Phosphatases by Marco Antonio Lacerda-Abreu and José Roberto Meyer- Fernandes in Journal of Cancer Research Crimson Publishers _  Novel Approaches in Cancer Study Inorganic phosphate (Pi) is essential for several biochemical reaction. Serum Pi is maintained at relatively narrow range concentrations, between 0.7 and 1.55mM. Tumor microenvironment presents a high Pi concentration (1.8±0.2mM Pi) and this could be associated wi the rapid growth in the “Growth Rate Hypothesis”. Several studies have identified high expression of Pi transporters in various tumor tissues. Similarly, ecto-enzymes (like ecto-nucleotidases or ecto- phosphates) act by dephosphorylating phosphosubstrates in the extracellular environment, and its high expression has been observed in various types of cancer. Little is known about the function of these ecto-enzymes on Pi releasing and accumulation in the tu...
Read more